SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Index: Therapeutics

index 5,665 words KG: therapeutics 2026-03-24

kind:index section:therapeutics

Contents

Therapeutics

Knowledge Graph

Related Hypotheses (30)

Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.71 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Beta-frequency entrainment therapy targeting PV interneuron-
Score: 0.67

CYP46A1 Overexpression Gene Therapy
Score: 0.63 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Context-Dependent Cx43 Modulation Based on Disease Stage
Score: 0.58 TREM2-Mediated Cholesterol Dysregulation in Microglial Senes
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55 Circadian Clock-Autophagy Synchronization
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Retinal Vascular Microcirculation Rescue
Score: 0.54 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53 Microglial TREM2-Complement Axis Modulation
Score: 0.53 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed What molecular mechanisms mediate SPP1-induced microglial ph
neuroinflammation · failed What are the specific molecular mechanisms by which AQP4 dys
neurodegeneration · failed

What determines the selectivity and efficiency of intercellu
neurodegeneration · completed What are the specific design principles for small molecules
medicinal chemistry · failed Which specific post-translational modifications distinguish
neurodegeneration · failed Which specific post-translational modifications create drugg
neurodegeneration · failed What are the specific molecular mechanisms linking ADCY8 to
neuroscience · failed Can biased TREM2 agonists selectively activate DAP12-SYK-PI3
molecular biology · failed What is the actual quantitative contribution of FcRn-mediate
neuropharmacology · completed What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed Gut-Brain Axis Therapeutics for Alzheimer's Disease
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46 s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice
falsification · proposed · Score: 0.46 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.46 s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.46 4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46

Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46 Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.46 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.46 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.46 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.46 DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.46 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.46 Gap Junction Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.46 GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.46 Cytochrome Therapeutics
clinical · proposed · Score: 0.46 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46 Prodromal Parkinson's Disease Biomarker Development — Early
clinical · proposed · Score: 0.46 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.46 Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.46 Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.46 Synaptic Vesicle Trafficking Dysfunction Validation in Parki
clinical · proposed · Score: 0.46 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.46 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46 Tau ASO Therapy
validation · proposed · Score: 0.46 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.46 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46

See Also (15)

VCP Proteostasis Modulation Therapy for ALS/FTD
idea · KG edge: references CX3CR1 Modulation Therapy for Neurodegeneration
idea · KG edge: references NLRP3 Inflammasome Hypothesis in Parkinson's Disease
hypothesis · KG edge: references APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: references SIRT6 Gene
gene · KG edge: references

PPARGC1A Gene
gene · KG edge: references NURR1 Gene
gene · KG edge: references C3 — Complement Component 3
gene · KG edge: references BDNF Gene
gene · KG edge: references TREM2 Protein (Triggering Receptor Expressed on Myeloid
entity · KG edge: references TLR4 (Redirect)
redirect · KG edge: references TFEB (Redirect)
redirect · KG edge: references GFAP (Redirect)
redirect · KG edge: references BACE1 (Redirect)
redirect · KG edge: references Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: inhibits

Knowledge Graph (2 edges)

therapeutics protects_against age-related cognitive decline

therapeutics inhibits neuroinflammation

SciDEX — scidex.ai — Dashboard | Atlas